Dr. Bevan Tandon, MD
Director, Cancer Genomics
Dr. Tandon holds subspecialty board certifications from the American Board of Pathology in both Molecular Genetic Pathology, and also Hematopathology. His general certifications are in anatomic and clinical pathology. Dr. Tandon’s training in hematopathology consisted of an intensive fellowship and clinical instructorship at the University of Pittsburgh School of Medicine under the guidance of WHO lead author Dr. Steven Swerdlow, and his training in molecular genetic pathology was conducted at Washington University in St. Louis School of Medicine. Dr. Tandon completed his general residency training at Northwestern University Feinberg School of Medicine. Dr. Tandon is an active member of the Society for Hematopathology, and the Association for Molecular Pathology.
Eric Antoniou, PhD
Assistant Director, Cancer Genomics
Dr. Antoniou earned his PhD from the University of Bordeaux, France. He was formerly the senior manager of Cold Spring Harbor Laboratory genome sequencing center. He also held management positions at Ginkgo Bioworks and The Jackson Laboratory. Prior to these positions, he was an Assistant Professor at the University of Missouri-Columbia. Dr. Antoniou has eighteen years of experience in genomics science, including nine years in next generation sequencing.
Zhixiong Xu, PhD, FACMG
Assistant Director of Cancer Cytogenetics
Zhixiong Xu is ABMGG-certified in Clinical Molecular Genetics and Clinical Cytogenetics. He joined GeneDx in 2013 and served as an Assistant Director of the Hereditary Cancer program. He received his BS in Biological Chemistry from Xiamen University and his PhD in Cell Biology from the Peking Union Medical College. He completed a postdoctoral fellowship in Molecular Oncology and was appointed Research Assistant Professor at the Vanderbilt-Ingram Cancer Center. While at the National Institutes of Health (NIH), he worked with Gary Felsenfeld in genetic and epigenetic regulation of gene expression, and completed his medical genetics fellowship training at the National Human Genome Research Institute (NHGRI). Dr. Xu was a recipient of the Hope Street Kids Fellowship Award and the American Society of Hematology Scholar Award.
- Clinical Targeted Next-Generation Sequencing Panel Testing in Non-Small Lung Cancer: Single Institution Experience at a High Scale National Reference Laboratory
- Extended Myeloid Mutation Profiling using NGS in Triple-Negative Myeloproliferative Neoplasms: Single Institution Experience at a High Volume National Reference Laboratory
- Assessing the Possibility of RUNX1, ETV6 and GATA2 Related Germline Predisposition in Myeloid Neoplasms in a Somatic Cancer Setting